Sanjar Pharma, a renowned manufacturer and supplier of high-quality Anti-Malarial injections, is taking a decisive step to strengthen malaria control efforts in Africa’s most severely impacted countries by providing direct access to its products. With this initiative, clinics and hospitals across Zambia, Kenya, Nigeria, Uganda, Namibia, and South Africa can now source Arteether, Artemether, and Quinine Dihydrochloride injections directly from the company, bypassing third-party channels to ensure timely delivery and competitive pricing.

Tackling Malaria: A Global Priority
Malaria remains a significant public health challenge, particularly in the WHO African Region, where an alarming 94% of global malaria cases and 95% of related deaths were reported in 2022. Children under five years of age accounted for nearly 78% of these fatalities, highlighting the urgent need for effective and accessible treatments. Countries like Nigeria, the Democratic Republic of the Congo, Uganda, and Mozambique collectively contribute to nearly half of the global malaria burden, making the availability of high-quality anti-malarial drugs crucial for reducing the mortality rate.

Sanjar Pharma’s Anti-Malarial Solutions
To address this critical need, Sanjar Pharma offers three powerful anti-malarial injection solutions tailored to combat the deadliest forms of malaria:

Arteether Injection: Specifically designed to treat severe malaria caused by Plasmodium falciparum, Arteether is administered intramuscularly and is especially effective when oral medication is not feasible due to complications like vomiting.

Artemether Injection: A fast-acting solution used in combination with lumefantrine to treat acute uncomplicated malaria. It works by rapidly reducing the parasite load within 48 hours, preventing severe complications such as cerebral malaria and organ failure.

Quinine Dihydrochloride Injection: This potent treatment targets blood-stage parasites and is typically used in critical cases with high parasite loads. It can be administered intravenously or intramuscularly and is often combined with other antimalarial drugs for enhanced efficacy.

Streamlining Access: Direct Procurement for African Healthcare Providers
Sanjar Pharma’s new direct access initiative simplifies the procurement process for healthcare providers in Africa, allowing them to place bulk orders without the need for third-party intermediaries. This streamlined approach results in faster delivery times, more competitive pricing, and a smoother ordering experience. Clinics and hospitals can now procure these life-saving anti-malarial injections starting from as low as $200 per bulk order.

Our goal is to empower healthcare providers in malaria-affected regions with affordable, high-quality anti-malarial medications,” said a spokesperson from Sanjar Pharma. “By offering direct access to our products, we aim to eliminate supply chain delays and ensure that critical medications are available where they are needed the most.”

About Sanjar Pharma
Founded in 2014 and headquartered in Himatnagar, Gujarat, Sanjar Pharma is a rapidly growing pharmaceutical company specializing in the manufacturing of various injectable formulations, including dry powder injections, liquid vials, ampoule injections, PFS injections, and suspension injections. The company’s extensive product portfolio also includes ear and eye drops, reflecting its commitment to addressing diverse healthcare needs. Sanjar Pharma’s products are trusted by patients and healthcare providers across multiple regions, underscoring its dedication to improving global health outcomes.

Contact Information
To learn more about Sanjar Pharma’s anti-malarial injections or to place a direct order, healthcare providers are encouraged to reach out via the following channels:

Email: [email protected]
WhatsApp: +916352986603
Call: 02772-245249

Sanjar Pharma invites healthcare providers across Africa to experience the benefits of its direct access initiative, ensuring a reliable supply of effective anti-malarial treatments at competitive prices. Together, let’s work towards a healthier future, free from the burden of malaria.